NHANCE

Welcome to the Brand page for “NHANCE”, which is offered here for [ medicines, antibodies for the treatment of infectious diseases and inflammation and for use in oncology; medicines for the treatment of infectious diseases and inflammation and for use in oncology; medicines for autoimmune inflammatory disorders ];enhance;research and development in the field of biotechnology; research into new drugs and development of drugs; providing scientific and technical research services in the field of biotechnology and genetics, and research and design relating thereto; [ industrial analysis in the nature of biochemical analyses and research services in the field of biotechnology; laboratories, medical laboratory services; ] providing medical and scientific research information and advice in the field biotechnology;.

Its status is currently believed to be active. Its class is unavailable. “NHANCE” is believed to be currently owned by “argenx, besloten vennootschap met beperk”.

Owner:
ARGENX, BESLOTEN VENNOOTSCHAP MET BEPERK
Owner Details
Description:
[ Medicines, antibodies for the treatment of infectious diseases and inflammation and for use in oncology; medicines for the treatment of infectious diseases and inflammation and for use in oncology; medicines for autoimmune inflammatory disorders ];ENHANCE;Research and development in the field of biotechnology; research into new drugs and development of drugs; providing scientific and technical research services in the field of biotechnology and genetics, and research and design relating thereto; [ industrial analysis in the nature of biochemical analyses and research services in the field of biotechnology; laboratories, medical laboratory services; ] providing medical and scientific research information and advice in the field biotechnology;
Categories: MEDICINES